WEIGHT LOSS INJECTIONS AT LASERAWAY

Step 1

By clicking the below button, I consent to receive calls, emails and text messages using automated technology from LaserAway at the phone number and email address provided. I understand that this is not a condition of purchase. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

WEIGHT LOSS x LASERAWAY

At LaserAway, we pride ourselves on helping patients across the country ignite their inner confidence by safely providing them with the most cutting-edge products and services on the market. We’re considering all options as we build out our weight loss offering—sign up here to be the first to know when we launch!

ARE WEIGHT LOSS INJECTIONS RIGHT FOR ME?

Struggle with obesity, type 2 diabetes or another weight-related health issue? Then weight loss injections (paired with a reduced-calorie meal plan and increased physical activity) could be the answer.

IT’S ALL IN THE NAME
These are some of the hottest FDA-approved products available.

laseraway image for Weight Loss Injections

Ozempic® (semiglutide)

Lose weight with a weekly shot
Regulate blood sugar and decrease appetite
Currently approved for those with type 2 diabetes*

Wegovy® (semiglutide)

Lose up to 15% of your body weight in one year**
Improve blood pressure, cholesterol and blood sugar
Currently approved for those with obesity and other weight-related health issues

Mounjaro® (tirzepatide)

Lose up to 25 pounds in one year***
Regulate blood sugar and decrease appetite
Currently approved for those with type 2 diabetes

*Ozempic® is not a weight-loss drug. In the same 2 studies looking at A1C, adults with type 2 diabetes lost on average: Ozempic®: 8 lb (0.5 mg) and 10 lb (1 mg) vs placebo: 3 lb Ozempic®: 12 lb (1 mg) and 14 lb (2 mg) from an average starting weight of 202 lb and 219 lb, respectively.

**Wegovy® Results are from a 68-week medical study of adults with obesity (BMI ≥30) and adults with excess weight (BMI ≥27) who also had weight-related medical problems including high blood pressure or high cholesterol. People with type 2 diabetes were excluded. Both groups received instruction for a reduced-calorie meal plan and increased physical activity. 7% of people taking Wegovy® (92 people) left the medical study due to side effects, compared to 3.1% of people taking placebo (20 people).

***Mounjaro® is not a weight loss drug. ‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).